ChemBriefMetis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech
Hong Kong-listed Metis TechBio signed a collaboration agreement with Eli Lilly worth up to $1.1 billion for the R&D of tissue-specific drug delivery technologies.
reuters · 2026-10-19 03:36